THE PEW CHARITABLE TRUSTS named 22 early-career researchers as Pew scholars in the biomedical sciences—as well as five scholars for cancer research, funded in partnership with the Alexander and Margaret Stewart Trust.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
